Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.

Choi, Sung R., Howell, Owain W., Carassiti, Daniele, Magliozzi, Roberta, Gveric, Djordje, Muraro, Paolo A., Nicholas, Richard, Roncaroli, Federico +1 more·2012·Brain
DOI 10.1093/brain/aws189

Cited by (385)

Items 301–385 of 385

  1. Intrathecal Immunoglobulin Synthesis in MS—A Complete Reappraisal
    Mickaël Bonnan · 2016 · InTech eBooks
  2. The best basic science paper in multiple sclerosis in 2013: Disease specific molecular events in cortical multiple sclerosis lesions
    Michael Hutchinson · 2014 · Multiple Sclerosis Journal
  3. Inflammatory Demyelinating Diseases of the Central Nervous System
    Minshu Li, Qiang Liu · 2024 · Advances in neurobiology
  4. ODC1 restricts meningeal B cell age-associated-like phenotype and function in multiple sclerosis: A human and experimental study
    Jonathan D. Zurawski, Alara Tuncer, Martin R. Profant, Jianuo Wang, Miranda Green, Yoobhin Park, Ke Cao, Simon Paris, Shahamat Tauhid, Youmna Jalkh et al. · 2026 · Proceedings of the National Academy of Sciences
  5. Serum and CSF cytokine profile impact clinical phenotype in pediatric MOGAD
    Eri Ohashi, Kuniko Kohyama, Takayuki Mori, Shinpei Matsuda, Hiroya Nishida, Sahoko Miyama, Itaru Hayakawa, Yuichi Abe, Naoki Yamada, Motomasa Suzuki et al. · 2026 · Journal of Neuroinflammation
  6. Neurodegeneration correlates of iron-related lesions and leptomeningeal inflammation in multiple sclerosis clinical subtypes
    Aigli G. Vakrakou, Ioannis Papadopoulos, Maria-Evgenia Brinia, Dimitriοs Karathanasis, Dimitrios Panaretos, Panos Stathopoulos, Anastasia Alexaki, Varvara Pantoleon, Efstratios Karavasilis, Georgios Velonakis et al. · 2025 · Neuroradiology
  7. Aktuelle Therapien und Zukunftsoptionen für die progrediente Multiple Sklerose
    Simon Faissner, Ralf Gold · 2018 · InFo Neurologie + Psychiatrie
  8. Mitochondrial Dysfunction in EAE Mice Brains and Impact of HIF1-α Induction to Compensate Energy Loss
    Mahboobeh Mosavi-Mehr, Seyed Alireza Mesbah‐Namin · 2020 · Archives of Neuroscience
  9. Acute, Chronic, and Nonclassical Neuroinflammation: Definitions in a Changing Scientific Environment
    Robert P. Lisak, Joyce A. Benjamins · 2013 · Advances in neurobiology
  10. Overview of Promising Rat Models for Cortical Lesion Research- 2006 Until Now
    Sonja Hochmeister · 2018 · Journal of Neurology and Neuromedicine
  11. Insights and challenges on animal models for progressive multiple sclerosis
    Nalepa, Isabella F., Haahr, Nicolai O., Bekiaris, Vasileios, Jakobsen, Martin R., Asuni, Ayodeji A., Benmamar-Badel, Anouk · 2026 · Journal of Neuroinflammation
  12. The microbiome-gut-brain axis in multiple sclerosis
    Dušan Radojević, Svetlana Soković Bajić, Miroslav Dinić, Aleksandar Bisenić, Jelena Đokić, Nataša Golić · 2023 · Arhiv za farmaciju
  13. Downregulation of dual-specificity phosphatase 1 (DUSP1) in post-mortem brain white matter in progressive multiple sclerosis
    Martí Oró-Nolla, Melody Cui Sun, Thomas P. Reilly, Julia Anandarajah, Almudena Otálora-Alcaraz, Lisa Costelloe, HUGH F. KEARNEY, Richard Magee, Yvonne M. Nolan, Eric J. Downer · 2026 · Neurological Sciences
  14. Bruton’s Tyrosine Kinase Inhibitors in Multiple Sclerosis: Mechanistic Considerations Across Relapsing and Progressive Disease
    Qiying Ye, Siming Ma · 2026 · Molecules
  15. Pathological extracellular matrix changes in decellularized normal appearing gray matter and subpial multiple sclerosis lesions
    Jody M. de Jong, Justina Clarinda Wolters, Marion H. C. Wijering, Joop de Vries, Susanne M. Kooistra, Bart J. L. Eggen, Wia Baron · 2026 · iScience
  16. Signes et symptômes de la sclérose en plaques
    Bruno Brochet, Christine Lebrun‐Frénay, Jerome De Seze, Hélène Zéphir, E. Allart, Bertrand Audoin, Xavier Ayrignac, Caroline Bensa, Anne Blanchard-Dauphin, David Brassat et al. · 2017 · Elsevier eBooks
  17. Physical Impairments Associated with Diseases: A Pathophysiological Approach
    Vignesh Kotian, Leela Mounica, Deepaneeta Sarmah, Harpreet Kaur, Geetesh Verma, Radhika Kesharwani, Pabbala Veeresh, Anupom Borah, Kiran Kalia, Pallab Bhattacharya · 2019 · Springer eBooks
  18. Modification of T- and B-cell-associated immuno-pathologic mechanisms in multiple sclerosis by disease modifying therapies: Achievements and opportunities
    Joost Smolders, Jörg Hamann, Inge Huitinga · 2024 · Handbook of clinical neurology
  19. Pathologie und Immunpathogenese der Multiplen Sklerose
    Christine Stadelmann · 2013 · Springer eBooks
  20. Current model of immunopathogenesis of multiple sclerosis – new therapeutic options
    Halina Bartosik-Psujek · 2014 · Aktualności Neurologiczne
  21. Gut Microbiota in Brain Development and Disorders of the CNS: Therapeutic Strategies Involving Dietary Modification, Pro- and Prebiotic Intervention, and Fecal Microbiota Transplantation (FMT) Therapy
    Bryan C. Tungland · 2018 · Elsevier eBooks
  22. B Cell-based Therapies for Multiple Sclerosis
    Michael Osherov, Ron Milo · 2019 · Royal Society of Chemistry eBooks
  23. Multiple Sclerosis: Where Do We Go From Here?
    Marta Tejera‐Alhambra, Lidia Fernández-Paredes, Clara de Andrés, Silvia Sánchez‐Ramón · 2016 · EMJ Neurology
  24. Distribution of multiple sclerosis lesions detected by brain magnetic resonance imaging in Erbil city
    Dina Nasih Tawfeeq, Shawnam Dawood · 2021 · Zanco Journal of Medical Sciences
  25. New concepts on immunology of Multiple Sclerosis
    Laura Couloume, Laure Michel · 2021 · La Presse Médicale
  26. Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammation
    Dejan Jakimovski, Ferhan Qureshi, Murali Krishna Ramanathan, Kian Jalaleddini, Ati Ghoreyshi, Michael G. Dwyer, Niels Bergsland, Bianca Weinstock‐Guttman, Robert Zivadinov · 2024 · Journal of the Neurological Sciences
  27. Live imaging of autoimmune responses in distinct milieus of the central nervous system
    Corinna S. Schlosser · 2013
  28. Myeloid-Derived Suppressor Cells are relevant factors to predict the severity of multiple sclerosis
    María Cristina Ortega, Rafael Lebrón‐Galán, Isabel Machín-Díaz, Michelle Naughton, Inmaculada Pérez-Molina, Jennifer García-Arocha, José Manuel García‐Domínguez, Haydee Goicoechea-Briceño, Virginia Vila‐del Sol, Víctor Quintanero-Casero et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  29. Neuronal pathology in targeted cortical experimental autoimmune encephalomyelitis and multiple sclerosis
    Tanja Jürgens · 2013
  30. The ‘best’ basic science paper on multiple sclerosis in 2012
    Don Mahad · 2013 · Multiple Sclerosis Journal
  31. Innate immunity in progressive multiple sclerosis
    Shahin Aeinehband · 2015 · Figshare
  32. Immunopathogenesis of cortical demyelination in Multiple Sclerosis
    Nielsen Lagumersindez-Denis · 2015
  33. Demyelinating Diseases and Neuroinflammation
    Manmeet Singh, Jayasri Das Sarma · 2016 · Springer eBooks
  34. Role of meningeal inflammation in cortical pathology and disease progression of multiple sclerosis
    Daniele Carassiti · 2012
  35. L’inflammation microscopique dans la sclérose en plaques : inflammation focale et inflammation diffuse
    Hélène Zéphir · 2017 · Pratique Neurologique - FMC
  36. Neue Therapieansätze bei progredienter Multipler Sklerose
    Simon Faissner, Ralf Gold · 2018 · Neurologie up2date
  37. Experimental models of cortical multiple sclerosis pathology
    Maarten E. Witte, Jack van Horssen · 2017 · Drug Discovery Today Disease Models
  38. Elucidating the functions of fibroblast growth factor 9 in multiple sclerosis
    Daniel McElroy · 2018 · Enlighten: Theses (The University of Glasgow)
  39. Kortikale Demyelinisierung bei entzündlichen, neoplastischen und metabolischen ZNS-Erkrankungen
    Jadwiga Zyta Wozniak · 2018
  40. IMAGE DERIVED INPUT FUNCTION FOR BRAIN [11C]TMSX PET IMAGING
    Imran Waggan · 2019 · UTUPub (University of Turku)
  41. Immunologie de la sclérose en plaques
    Gilles Louis Defer, Marc Debouverie, Isabelle Bardou, Mehdi Benamar, Raphaël Bernard‐Valnet, Pierre Branger, David Brassat, Naïl Benallegue, Floriane Calocer, Vincent Damotte et al. · 2019 · Elsevier eBooks
  42. Intérêt du rituximab dans les SEP progressives
    Kévin Bigaut, Nicolas Collongues · 2019 · Pratique Neurologique - FMC
  43. Neue Therapieansätze bei progredienter Multipler Sklerose
    Simon Faissner, Ralf Gold · 2020 · Neuroradiologie Scan
  44. Imaging of Demyelination, Repair and Remyelination in Multiple Sclerosis
    Shahrukh Mallik · 2020 · UCL Discovery (University College London)
  45. Studies of the Biology of Intrathecal Treatment in Progressive MS
    Joakim Bergman · 2020 · DiVA at Umeå University (Umeå University)
  46. Investigating the Relationship Between Cortical Grey Matter Hypoxia and Disability in Multiple Sclerosis
    Evans, Taelor · 2020
  47. Literatur
    2021 · Elsevier eBooks
  48. Analysis of autoimmune lesions in grey matter
    Moritz Hermann · 2018
  49. Multiple sclerosis
    Xiaoming Jia, Sergio E. Baranzini, Stephen L. Hauser · 2020 · Elsevier eBooks
  50. Faculty Opinions recommendation of Progression of regional grey matter atrophy in multiple sclerosis.
    Peter K. Stys · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  51. Characterization of immune responses in the meninges
    Arianna Merlini · 2022
  52. Pathogénie et physiopathologie de la sclérose en plaques
    Bruno Brochet · 2022 · Elsevier eBooks
  53. IMMUNOREGULATION OF MULTIPLE SCLEROSIS BY HELMINTH THERAPY
    Editha Renesteen · 2020 · JFIOnline
  54. Peer Review #1 of "Discovery of grey matter lesion-related immune genes for diagnostic prediction in multiple sclerosis (v0.2)"
    2023 · PeerJ
  55. Peer Review #1 of "Discovery of grey matter lesion-related immune genes for diagnostic prediction in multiple sclerosis (v0.1)"
    2023 · PeerJ
  56. Peer Review #2 of "Discovery of grey matter lesion-related immune genes for diagnostic prediction in multiple sclerosis (v0.2)"
    2023 · PeerJ
  57. Peer Review #2 of "Discovery of grey matter lesion-related immune genes for diagnostic prediction in multiple sclerosis (v0.1)"
    2023 · PeerJ
  58. Mechanisms of Neurodegeneration in Multiple Sclerosis
    Daria D. Eliseeva, Mariya N. Zakharova · 2023 · Neuroscience and Behavioral Physiology
  59. Functional Neuroradiology of Multiple Sclerosis: Non-BOLD Techniques
    Francesca Benedetta Pizzini, Giacomo Talenti · 2023 · Springer eBooks
  60. Introduction to the neuroimmunology of multiple sclerosis
    Niloufar Yazdanpanah, Nima Rezaei · 2023 · Elsevier eBooks
  61. Sudden Death Is More Likely to Result From SARS-COV-2 Infection Than Multiple Sclerosis
    Josef Finsterer · 2023 · Journal of Korean Medical Science
  62. Estudo da atividade de células citotóxicas em portadores de esclerose múltipla em uso de diferentes tratamentos
    Vinicius de Oliveira Boldrini · 2020
  63. Neurodegeneration in autoimmune central nervous system infection
    Anuradha Kesharwani, Vikash Kumar, Vulli Aravind, Krishna Murti, Vipan Kumar Parihar · 2024 · Elsevier eBooks
  64. B cells in multiple sclerosis
    Angela A. Wang, Jennifer L. Gommerman · 2024 · Elsevier eBooks
  65. Multiple sclerosis: Clinical course, open questions, unmet clinical needs
    Jonathan D. Zurawski, Howard L. Weiner · 2024 · Elsevier eBooks
  66. Multiple sclerosis
    Xiaoming Jia, Jorge R. Oksenberg, Stephen L. Hauser, Sergio E. Baranzini · 2024 · Elsevier eBooks
  67. Demyelinating Disease
    Danielle M. Howard, Jonathan D. Zurawski · 2024 · Elsevier eBooks
  68. Relationship of cranial bone signal intensity to multiple sclerosis clinical course and progression
    Furkan Sarıdaş, Rıfat Özpar, Ülkünur Özdemir, Yasemin Dinç, Emel Oğuz Akarsu, Emine Rabia Koç, Güven Özkaya, Bahattin Hakyemez, Ömer Faruk Turan · 2025 · Science Progress
  69. The Effects of Saffron on Hippocampal Glial Fibrillary Acidic Protein, Olig2 Gene Expression, and Pathological Changes in Cuprizone-Induced Demyelinated Rats
    Leila Khaledi, Mahnaz Taherianfard, Mehran Ghaemi, Azizollah Khodakaram‐Tafti, Hamid Reza Moradi, Maryam Asadian Ghahfarokhi, Mohamad Sadegh Golvajoei · 2025 · SSRN Electronic Journal
  70. Papel dos neutrófilos nas meninges para o desenvolvimento da dor neuropática
    Rafaela da Silva Castro · 2024
  71. The Effects of Saffron on Hippocampal Glial Fibrillary Acidic Protein, Olig2 Gene Expression, and Pathological Changes in Cuprizone-Induced Demyelinated Rats
    Mahnaz Taherianfard, Leila Khaledi, Mehran Ghaemi, Azizollah Khodakaram‐Tafti, Hamid Reza Moradi, Maryam Asadian Ghahfarokhi, Mohamad Sadegh Golvajoei · 2025 · SSRN Electronic Journal
  72. Additional file 1 of BAFF blockade in experimental autoimmune encephalomyelitis reduces inflammation in the meninges and synaptic and neuronal loss in adjacent brain regions
    Gupta, Kanak, Ajay Kesharwani, Steven Rua, Singh, Saumitra Sen, Catherine Siu, Larissa Jank, Matthew D. Smith, Calabresi, Peter A., Bhargava, Pavan · 2024 · Figshare
  73. Role of neutrophils in the meninges for the development of neuropathic pain
    Rafaela da Silva Castro · 2024 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  74. Identification de programmes d'activation macrophagique et microgliale dans les formes progressives de la sclérose en plaques
    Alice Lhuillier · 2014 · theses.fr (ABES)
  75. The reorganization of human brain networks in the early stages of multiple sclerosis
    Ismail Koubiyr · 2019
  76. Characterization of spinal cord lesions in the marmoset EAE model using MRI and histopathology techniques
    Jennifer Lefeuvre · 2019 · theses.fr (ABES)
  77. Investigation of regulatory plasma cells in health and disease
    Thi Cuc Bui · 2022 · theses.fr (ABES)
  78. Etude des conséquences des altérations de la myéline sur les fonctions cognitives à la suite d’un épisode transitoire de démyélinisation chez la souris adulte
    Océane Mercier · 2022 · theses.fr (ABES)
  79. Contribution des neuroblastes dérivés de la zone sous ventriculaire à la régénération de la myéline dans le cerveau de souris adulte : impact des propriétés mécaniques des tissus
    Marie Falque · 2023 · theses.fr (ABES)
  80. Intrathecal IgM species as potential prognostic biomarkers in relapsing-remitting multiple sclerosis
    Charlotte Hvaring, Noor Alawad, Øyvind Olav Salvesen, Harald Hovdal, Linda Rosemary White, Anne Isabelle Boullerne · 2026 · Multiple Sclerosis and Related Disorders
  81. Phytochemicals Potentially Applied to Noncommunicable Diseases
    Haixia Chen, Wen Zhang, Siyu Wang, Yiping Li, Lim Eng Keat · 2026 · Interdisciplinary biotechnological advances
  82. C3 and C5 complement cascade activation in brain injury and disease: Molecular mechanisms, pathological roles, and therapeutic implications
    Geoffrey E. Woodard · 2026 · Neurochemistry International
  83. Recognition and management of acute relapse of multiple sclerosis, neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease
    Yu-Jing Li, Wei Jiang, Chao Zhang, Paulus Stefan Rommer, Michael Levy, Friedemann Paul, Fu‐Dong Shi · 2026 · Cell Death and Differentiation
  84. Exploring the relationship between white and grey matter damage in primary progressive multiple sclerosis with structural magnetic resonance imaging
    Benedetta Bodini · 2013 · UCL Discovery (University College London)
  85. Untersuchungen zur Pathogenese subpialer kortikaler Läsionen bei Multipler Sklerose und bei Marmosetten mit experimenteller autoimmuner Enzephalomyelitis
    Zimmermann, Katharina · 2015